Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.

Biotechnology

Mozart Therapeutics

Katie Fanning

Russ Hawkinson

Jennifer More

Courtney Crane

Kristine Swiderek

The Directors Team at Mozart Therapeutics is responsible for strategic decision-making, guiding the company's vision, and ensuring the successful development of its novel CD8 Treg modulators. This team provides leadership across various functions, including research, development, human resources, and operations, to drive the company’s mission of creating disease-modifying therapies for autoimmune and inflammatory diseases.

Directors Team

Research and Development

Leadership Team

Directors Team

About

Team members

Other teams at Mozart Therapeutics

Research and Development

Leadership Team